Are Medical Stocks Lagging Amneal Pharmaceuticals (AMRX) This Year?

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Amneal Pharmaceuticals (AMRX) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.Amneal Pharmaceuticals is a member of the Medical sector. This group includes 961 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Amneal Pharmaceuticals is currently sporting a Zacks Rank of #2 (Buy).Over the past three months, the Zacks Consensus Estimate for AMRX's full-year earnings has moved 8.9% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.According to our latest data, AMRX has moved about 31.1% on a year-to-date basis. In comparison, Medical companies have returned an average of 2.6%. This means that Amneal Pharmaceuticals is outperforming the sector as a whole this year.Another stock in the Medical sector, ANIXA BIOSCIENCES INC (ANIX), has outperformed the sector so far this year. The stock's year-to-date return is 46.1%.For ANIXA BIOSCIENCES INC, the consensus EPS estimate for the current year has increased 7.9% over the past three months. The stock currently has a Zacks Rank #2 (Buy).To break things down more, Amneal Pharmaceuticals belongs to the Medical - Drugs industry, a group that includes 147 individual companies and currently sits at #82 in the Zacks Industry Rank. On average, stocks in this group have gained 13% this year, meaning that AMRX is performing better in terms of year-to-date returns. On the other hand, ANIXA BIOSCIENCES INC belongs to the Medical - Biomedical and Genetics industry. This 472-stock industry is currently ranked #73. The industry has moved +9% year to date.Investors interested in the Medical sector may want to keep a close eye on Amneal Pharmaceuticals and ANIXA BIOSCIENCES INC as they attempt to continue their solid performance.Free Report: Profiting from the 2nd Wave of AI ExplosionThe next phase of the AI explosion is poised to create significant wealth for investors, especially those who get in early. It will add literally trillion of dollars to the economy and revolutionize nearly every part of our lives.Investors who bought shares like Nvidia at the right time have had a shot at huge gains.But the rocket ride in the "first wave" of AI stocks may soon come to an end. The sharp upward trajectory of these stocks will begin to level off, leaving exponential growth to a new wave of cutting-edge companies.Zacks' AI Boom 2.0: The Second Wave report reveals 4 under-the-radar companies that may soon be shining stars of AI’s next leap forward.Access AI Boom 2.0 now, absolutely free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AMNEAL PHARMACEUTICALS, INC. (AMRX): Free Stock Analysis Report ANIXA BIOSCIENCES INC (ANIX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks